Cargando…
Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson’s and Alzheimer’s disease
Myeloperoxidase (MPO) is a key enzyme in inflammatory and degenerative processes, although conflicting reports have been presented concerning its expression in the brain. We studied the cellular localization of MPO and compared numbers of MPO cells in various brain regions between neurologically hea...
Autores principales: | Gellhaar, Sandra, Sunnemark, Dan, Eriksson, Håkan, Olson, Lars, Galter, Dagmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579172/ https://www.ncbi.nlm.nih.gov/pubmed/28466093 http://dx.doi.org/10.1007/s00441-017-2626-8 |
Ejemplares similares
-
Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden
por: Ran, Caroline, et al.
Publicado: (2016) -
Chronic L-DOPA induces hyperactivity, normalization of gait and dyskinetic behavior in MitoPark mice
por: Gellhaar, S, et al.
Publicado: (2015) -
Multiscale structural mapping of Alzheimer’s disease neurodegeneration
por: Jang, Ikbeom, et al.
Publicado: (2022) -
Genetic Screening of the Mitochondrial Rho GTPases MIRO1 and MIRO2 in Parkinson’s Disease
por: Anvret, Anna, et al.
Publicado: (2012) -
Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease
por: Iaccarino, Leonardo, et al.
Publicado: (2017)